Wolf Hill Capital Management LP Makes New Investment in Teleflex Incorporated $TFX

Wolf Hill Capital Management LP bought a new position in shares of Teleflex Incorporated (NYSE:TFX) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 388,440 shares of the medical technology company’s stock, valued at approximately $47,405,000. Teleflex comprises about 5.2% of Wolf Hill Capital Management LP’s investment portfolio, making the stock its 7th largest holding. Wolf Hill Capital Management LP owned approximately 0.88% of Teleflex at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of TFX. Empowered Funds LLC grew its position in Teleflex by 15.8% during the 1st quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the last quarter. Jane Street Group LLC boosted its holdings in shares of Teleflex by 42.6% in the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock valued at $877,000 after acquiring an additional 1,895 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Teleflex by 32.7% in the 2nd quarter. American Century Companies Inc. now owns 13,640 shares of the medical technology company’s stock valued at $1,614,000 after acquiring an additional 3,360 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Teleflex by 1.2% in the 2nd quarter. Invesco Ltd. now owns 135,516 shares of the medical technology company’s stock valued at $16,040,000 after acquiring an additional 1,659 shares during the last quarter. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Teleflex by 108.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,003 shares of the medical technology company’s stock valued at $119,000 after acquiring an additional 521 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on TFX. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 28th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Friday, March 27th. Truist Financial reaffirmed a “hold” rating and issued a $143.00 price objective (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Raymond James Financial reaffirmed an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Finally, Mizuho set a $140.00 price target on shares of Teleflex in a report on Friday, May 8th. Four equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Teleflex currently has a consensus rating of “Hold” and a consensus target price of $146.00.

Teleflex Stock Performance

NYSE:TFX opened at $130.24 on Monday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. The company has a fifty day moving average of $128.67 and a two-hundred day moving average of $118.98. The stock has a market capitalization of $5.77 billion, a PE ratio of -5.71, a P/E/G ratio of 0.97 and a beta of 0.82. Teleflex Incorporated has a fifty-two week low of $100.18 and a fifty-two week high of $139.67.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The firm’s revenue for the quarter was up 32.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, research analysts forecast that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.